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 The retinal pigment epithelium (RPE) is a monolayer of
pigmented cells that closely interacts with photoreceptors to
maintain their structural integrity and excitability [1-4]. A
changed growth factor secretion by the RPE is believed to be
involved in the etiology of proliferative eye diseases,such as
choroidal neovascularization (CNV) [5-8] in age-related macu-
lar degeneration (AMD), which is the most common cause
for legal blindness in industrialized countries [9]. Mainly a
changed growth factor secretion by the RPE seems to be of
importance for initiating CNV: increased secretion of pro-an-
giogenic factors and decreased secretion of anti-angiogenic
factors. CNV, representing the most severe complication in
AMD, originates in choroidal blood vessels that grow through
Bruch’s membrane into the sub RPE as well as the subretinal
space. In many studies, but especially in recent clinical trials,
vascular endothelial growth factor (VEGF) appears to be the
major angiogenic factor in this process.
Several studies using cultured or freshly isolated RPE cells
from various species demonstrated the expression of L-type
Ca2+ channels [10-15]. L-type Ca2+ channels represent a group
of high-voltage activated Ca2+ channels [16,17]. Studies ex-
amining the regulation of L-type channels of the RPE sug-
gested that these Ca2+ channels provide a Ca2+-influx pathway
involved in growth factor-dependent intracellular signaling
[12,15]. Activation of L-type channels in the RPE by the cy-
tosolic subtype tyrosine kinase pp60c-src shifts the voltage-de-
pendent activation to a more negative voltage-range, closer to
the resting potential of RPE cells [12,18]. This leads to a higher
number of active channels and, thus, an increase in intracellu-
lar free Ca2+. In this way, high-voltage-activated Ca2+ chan-
nels can contribute to intracellular signaling in epithelial cells.
A voltage-dependent activation in a rather negative voltage-
range has been discussed as a property of L-type channels
composed of Cav1.3 α-subunits [19-21]. The expression of
Cav1.3 subunits has been demonstrated in rat RPE cells [12,15].
Thus, L-type channels in RPE cells can participate in intracel-
lular signaling which could mediate changes in a yet unknown
RPE cell function.
L-type channels composed of the Cav1.3 α-channel-sub-
unit belong to the neuroendocrine subtype, because these chan-
nels are known to regulate the insulin secretion by β-islet cells
in the pancreas [16]. The RPE is known to secrete a variety of
growth factors like insulin like growth factor-1 (IGF-1), basic
fibroblast growth factor (bFGF or FGF2), VEGF or pigment
epithelium-derived factor (PEDF) [7,22-30]. In order to show
that L-type channels might regulate secretion rates in RPE
cells we studied voltage-dependent Ca2+ channels and the regu-
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L-type channels. Cells from CNV tissue also showed nifedipine-sensitive Ba2+ currents, which displayed a voltage-depen-
dent activation at more negative potentials, faster inactivation and changed regulation by tyrosine kinase pp60c-src. The
CNV RPE cells showed higher VEGF secretion rates which were reduced by nifedipine.
Conclusions: Thus, L-type Ca2+ channels in normal RPE cells regulate the secretion of VEGF. RPE cells from eyes with
CNV maintain a VEGF secretion regulated by nifedipine-sensitve Ca2+ channels which might be of importance for the
development of CNV.
Correspondence to: Olaf Strauss, Experimentelle Ophthalmologie,
Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum
Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany;
Phone: +49 40 42803 9469; FAX: +49 40 42803 5017; email:
o.strauss@uke.uni-hamburg.de
443lation of VEGF-A secretion by human RPE cells and by RPE
cells from surgically excised CNV tissues of AMD patients.
We found that VEGF secretion is dependent on the activity of
voltage-dependent Ca2+ channels, which might provide new
targets to prevent CNV by interventions at the source for
VEGF.
METHODS
Human tissue:  For the use of human material, tenets of the
Declaration of Helsinki were followed, informed consent was
obtained, and Institutional Human Experimentation Commit-
tee approval was granted for the studies. CNV membranes
were obtained directly after eye surgery of patients with AMD.
The mean and the range of the age of the patients are given in
Table 1. Patients with severe systemic diseases were not in-
cluded in the study. The human tissue was obtained about one
hour after eye surgery or enucleation and immediately pre-
pared for the experiments The detailed information is listed in
Table 1.
Patch-clamp recordings with freshly isolated cells:  A por-
tion of the CNV membranes was dissolved into single cell
suspension by enzymatic digestion using protease (10%) and
trypsin (0.1%). Cells from donor eyes without CNV were
placed into single-cell suspension by the same method. Cell
suspensions were placed onto a poly-lysine-coated glass cover
slip and allowed to settle. The cover slips were placed into the
perfusion chamber on the stage of an inverted microscope and
constantly superfused. The bath solution contained the fol-
lowing (given in mM): 136.4 NaCl, 1.1 NaH2PO4, 4.2 NaHCO3,
0.9 MgCl2, 0.95 CaCl2, 10.0 BaCl2, 5.8 TEACl, 25.0 HEPES,
and 11.1 glucose. Perforated-patch recordings were performed
with patch-pipettes of 3-5 mega-Ω resistance, using a pipette
solution that contained the following (given in mM): 100.0
CsCl, 10.0 NaCl, 2.0 MgSO4, 0.5 CaCl2, 5.5 EGTA, 10.0
HEPES, nystatin (150 mg/ml). For perforated-patch record-
ings from pigmented cells, we added an antibody against class
III β-tubulin (Sigma, Deisenhofen, Germany) to the pipette
solution. Currents were measured using an EPC-7 patch-clamp
amplifier in conjunction with TIDA hardware and software
(HEKA, Lamprecht, Germany). The freshly isolated cells
showed a membrane capacitance of 43.3±6.9 pF (n=10), and
access resistance of 12.5±2.0 mega-Ω (n=10). Access resis-
tance was compensated to values lower than 10 mega-Ω. Seals
were stable for approximately 3-7 min.
For stimulation of Ba2+ currents through L-type channels
cells were depolarized from a holding potential of -70 mV by
9 voltage-steps of 50 ms duration up to +20 mV (Figure 1A).
Measurements of maximal current density and kinetic param-
eters occurred at +10 mV to ensure data comparison at equal
biophysical driving forces.
Patch-clamp recordings from cultured cells:  CNV mem-
brane pieces not used for in situ investigations were employed
for growing RPE cell cultures, using the method of Schlunck
et al. [31]. Cultures from eyes without CNV were established
using the method of Aronson [32]. Recordings from cultured
cells were performed under the same conditions with the same
pipette and bath solutions as used for freshly isolated cells.
Purity of cell cultures was confirmed by immunohistochemi-
cal staining for class III β-tubulin, vimentin, cytokeratin 18,
glial fibrillary acidic protein (GFAP), and endothelial factor
8. Sub confluent cell cultures of both control RPE and CNV
RPE from the 5th to the 12th passage were used for patch-clamp
experiments. Mean membrane capacitance of cultured cells
was 128.9±17.8 pF (n=19); access resistance was 16.9±2.1
mega-Ω (n=19).
Intracellular application of pp60c-src:  During the whole
cell recording, 30 U/ml pp60c-src (>90% purity) was applied
via the patch-pipette employing a procedure described by Wang
and Salter [33]. In addition to pp60c-src (Biomol, Hamburg,
Germany), the pipette solution contained ATP (4x10-3 M) and
the extracellular solution DIDS (5x10-4 M) to block Cl- chan-
nels possibly activated by the application of ATP [34]. After
the patch was opened into the whole-cell configuration, the
maximal Ba2+ current amplitude was measured every 1 min
and plotted over the experimental time normalized to the am-
plitude measured directly after breaking into the whole-cell
configuration. As a control, a series of the same experiments
were performed with heat-inactivated pp60c-src (30 min at 95
°C).
Immunoblotting:  Membrane proteins were separated by
polyacrylamide gel electrophoresis (8.5% polyacrylamide;
Mini-Protean cells Bio-Rad Life Science Group, Hercules, CA;
for 1 h at 150 V), and 30 mg of total protein were loaded in
each lane. The proteins were blotted to nitrocellulose filter
screens (Polyscreen, NEN®, Life Science Products Boston,
MA) for 1 h at 100 V. Blots were blocked in phosphate buff-
ered saline (PBS/Tween) with nonfat dry milk (10%) for 2 h
and with bovine serum albumin (BSA; 5%) for 4 h at room
temperature. They were then probed overnight at 4 °C with
antibodies against Cav1.2 and Cav1.3 channel subunits and with
the peroxidase-conjugated secondary antibody for 1 h at room
temperature. Next, blots were visualized using a chemilumi-
nescence kit (Amersham Pharmacia Biotech, Braunschweig,
Germany) and digitized using the LAS-1000 Image Analyzer
(Fujifilm, Berlin, Germany) and the AIDA 2.0 software
(Raytest, Berlin, Germany). Specific staining was verified by
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TABLE 1. ORIGIN OF HUMAN TISSUE
Patient information       RPE       CNV
--------------------   --------   --------
Number of patients        7          18
Mean age of patients   69.0±1.6   70.7±4.0
Male                      3          7
Female                    4          11
Retinal pigment epithelium (RPE) was isolated from eyes without
choroidal neovascularization (CNV). These eyes were obtained from
multi organ donors after removal of cornea for transplantation. CNV
is derived from choroidal neovascular tissue of patients with age-
related macular degeneration (AMD); removal of CNV tissue was
indicated by individuell clinical picture. All AMD patients suffered
from wet AMD. Since only 46% of RPE cells in CNV tissue express
voltage-dependent channels, a larger number of patients is included
in this study.
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stripping blots and staining them a second time using the same
antibody together with the corresponding blocking peptide
(antibody: blocking peptide, 1:1).
Vascular endothelial growth factor secretion by retinal
pigment epithelium cells:  Confluent cell cultures were used
to study VEGF secretion by RPE cells. For this assay 100,000
cells were kept in a chamber of a 12-well plate. Every cham-
ber was equipped with 500 µl test solution (Dulbecco’s modi-
fied Eagle medium with 0.5% fetal calf serum). Beginning
with the last change of test medium, the concentration of
VEGF-165 was measured every 4 h in the test medium using
a commercially available ELISA kit (Biosource International,
Solingen, Germany) according to the manufacturer’s instruc-
tions. The number of experiments (n) includes the mean val-
ues of two repeated measurements of VEGF concentration in
the medium in one experiment.
Immunohistochemistry:  Freshly isolated and cultured
cells were stained with anti-class III β-tubulin antibody
(Sigma). The following procedure was used for freshly iso-
lated cells. After the perforated-patch recording of a pigmented
cell the patch was opened into a classical whole-cell configu-
ration, and negative voltage was applied to facilitate diffusion
of the antibody from the pipette into the cell. The patch-pi-
pette was removed from the cell, and the cell stayed attached
to the ground and could be subjected to immuno-staining. In
the first step, the cells underwent methanol-based fixation fol-
lowed by permeabilization with Triton X-100 (0.5% in PBS).
Then cells were washed several times and incubated with the
secondary fluorescence conjugated antibody. Cultured cells
underwent methanol-based fixation and permeabilization be-
fore they were incubated with the first antibody for 1 h. After
being placed through a series of washes cells were next incu-
bated with the secondary fluorescence conjugated antibody.
Fluorescence staining was visualized by analysis (Soft Imag-
ing System, Muenster, Germany).
Confluent cultures, which had been subjected to VEGF-
A secretion assay, were tested for their homogeneity by means
of immunohistochemistry methods as previously described in
reference [31]. In brief, cultures were rinsed with PBS and
fixed with acetone/PBS 1:1 followed with iced acetone. Cul-
tures were incubated with antibodies against cytokeratin 18
(Sigma), vimentin, glial fibrillary acidic protein (GFAP), en-
dothelial factor 8 (all from DAKO, Hamburg, Germany). Cell
nuclei were counter-stained with hematoxylin. Primary anti-
bodies were stained with alkaline phosphatase- or peroxidase-
labeled secondary antibodies (Sigma) with fast red as sub-
strate.
Statistics:  Numbers of experiments (n) with freshly iso-
lated cells correspond to numbers of individual AMD patients
or eyes without CNV. Data from cultured cells from CNV
membranes were obtained from three different cultures from
three different patients. All data are stated as mean±SEM. Data
were tested for statistical significance by ANOVA (Sigma Plot,
Systat Software, Inc., Point Richmond, CA). Significance was
considered at p-values lower than 0.05.
RESULTS
Voltage-dependent Ca2+ channels in freshly isolated cells:
Cells were identified as RPE cells by subsequent immunohis-
tochemical staining and fluorescence microscopy (Figure 1G,
Figure 2). For this purpose, the solution of the recording pi-
pette contained antibodies against class III β-tubulin, a marker
for RPE cells in both healthy and several forms of disease
[35]. Once the membrane currents were recorded, the anti-
body was intracellularly applied via dialysis by the solution in
the patch-pipette.
Freshly isolated RPE cells showed voltage-dependent in-
ward currents in the absence of potassium. With Ba2+ as charge
carrier, these cells responded to depolarization from a holding
potential of -70 mV (Figure 1B) to values more positive than
-30 mV with fast activating and inactivating inward currents
(Figure 1B). The currents showed a maximal current density
at +10 mV (Figure 1C) with 1.9±0.6 pApF-1 with a range from
1.4 to 2.8 pApF-1 (n=3; Figure 1F), a potential of the half maxi-
mal activation of -9.7±1.9 mV (n=3; Figure 3B), a time to
peak of 9.7±2.8 ms (n=3), and an inactivation time constant
of 53.9±10.3 ms (n=3).
In six out of 13 (46%) investigated CNV membranes, RPE
cells showed voltage-dependent Ba2+ currents (Figure 1D-G).
The mean current density of the maximal amplitude at +10
mV was 7.0±3.4 pApF-1 (n=6; current density ranged at +10
mV from 3.5 pApF-1 to 24.4 pApF-1), which was reached after
2.8±0.4 ms (n=6). This was faster than in cells from control
eyes (p=0.024). The potential of the half maximal activation
was -15.4±1.3 mV (n=6) which was significantly more nega-
tive than in cells from control eyes (p=0.0254). The currents
inactivated with a time constant of 12.6±2.3 ms (n=6). Thus,
inactivation was faster than in cells from control eyes
(p=0.00094).
The activation threshold at about -30 mV indicates that
the Ba2+ currents were in freshly isolated control cells and in
cells from CNV tissue currents through high-voltage-activated
(HVA) Ca2+ channels. Dihydropyridine nifedipine, a blocker
of an HVA channel subtype, the L-type Ca2+channels, inhib-
ited maximal current amplitudes to 39.4±6.3% (n=3) of con-
trol in freshly isolated RPE cells from eyes without CNV (Fig-
ure 3A,B,E). Application of nifedipine (10-5 M, Figure 3F,D,E)
reduced maximal current amplitudes to 20.7±7.5% (n=2) of
the control values in freshly isolated cells from CNV tissues.
The voltage-dependence of Ba2+ currents was not changed in
the presence of nifedipine in cells from CNV tissues as well
as in cells from eyes without CNV (Figure 3B,D).
Ba2+ currents in cultured cells:  To further examine the
cellular physiological characteristics of RPE cells, we devel-
oped cultures from CNV tissues by following the methods of
Schlunck et al. [31]. In order to test these cultures on their
origin and homogeneity, cultures were labeled with antibod-
ies against vimentin, cytoskeratin 18, endothelial factor 8, and
glial acidic fibrillary protein (GFAP). Cultures were homoge-
neously stained with antibodies against vimentin or cytokeratin
18 (Figure 2). No staining was observed using antibodies
against GFAP or endothelial factor 8. Identity of cells used for
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Figure 1. Voltage-dependent Ba2+ currents in freshly isolated cells.  A: Pattern of electrical stimulation to activate voltage-dependent Ba2+
currents. B: Ba2+ inward currents in a human retinal pigment epithelium (RPE) cell freshly isolated from an eye without choroidal
neovascularization (CNV). C: Current/voltage plot of currents from three freshly isolated cells from eyes without CNV D: Ba2+ inward
currents in a human RPE cell freshly isolated from CNV tissue. E: Current/voltage plot of currents from six freshly isolated cells from CNV
membranes. F: Comparison of maximal Ba2+ densities at +10 mV in freshly isolated cells. G: Class III β-tubulin staining of a freshly isolated
cell from CNV membrane after patch-clamp recording.
446patch-clamp recordings was confirmed by staining against
class III β-tubulin (Figure 1G).
RPE cells maintain the activity of voltage-dependent Ca2+
channels in culture (Figure 4 and Figure 5). The maximal cur-
rent density at +10 mV in cultured RPE cells from CNV mem-
branes was 3.9±0.8 pApF-1 (n=9) and in cultured RPE cells
from eyes without CNV (2.0±0.4 pApF-1, n=10; p=0.049).
Cells from CNV membranes had a time to peak of with
3.3±0.45 ms (n=9), which was faster than in cells from eyes
without CNV (11.9±1.4 ms, n=10; p=0.00004). Western blot
analysis of membrane proteins revealed the expression of
Cav1.3 subunits in cultured RPE cells from eyes without CNV
and in cells from CNV membranes. A weak expression of
Cav1.2 subunits could only be detected in RPE cells from eyes
without CNV (Figure 4G).
The currents in cultured cells were sensitive to the
dihydropyridine nifedipine, too (Figure 5). Application of
nifedipine reduced the maximal current amplitude measured
at +10 mV to 53.1±8.7% (n=4) in cells from CNV tissues and
to 60.1±4.8% (n=4) in cells from eyes without CNV. Further-
more, as in freshly isolated cells, the voltage-dependence of
Ba2+ currents was not influenced by nifedipine in both cells
from CNV tissues and cells from control eyes.
Vascular endothelial growth factor secretion:  Cultured
RPE cells release VEGF into the medium, a process that could
be stimulated by a test medium containing 0.5% fetal calf se-
rum. Under these conditions, we found that VEGF concentra-
tion increased with time in the test medium in both RPE cells
from eyes without CNV and in RPE cells from CNV mem-
branes. However, the VEGF concentration increased signifi-
cantly faster and reached higher concentrations in cultures
containing cells from CNV membranes when compared to
cultures of cells from eyes without CNV (Figure 6A). This
resulted in a higher VEGF secretion rate of 12.8 ± 1.4 pg/h
(versus no CNV: 5.4±0.9 pg/h; n=4; p=0.0475). Inhibition of
Ca2+ channels by nifedipine (10-5 M) reduced VEGF secretion
by both cell populations (Figure 6B,C). To confirm the con-
clusion that activation of voltage-dependent Ca2+ channels
leads to secretion of VEGF, we used the L-type channel Ca2+
channel modulator BayK8644 (10-5 M; Figure 6B,C) as (-)
enantiomer, which activates L-type channels and as the (+)
enantiomer, which inhibits L-type channels. The (-) BayK8644
increased the VEGF secretion rate by RPE cells from eyes
without CNV (Figure 6B), whereas it only slightly increased
the VEGF-A secretion rate in cells from CNV membranes
(Figure 6C). The latter effect was not statistically significant.
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Figure 2. Analysis of retinal pigment epithelium cell cultures from CNV membranes.  Sub-confluent cultures of retinal pigment epithelium
(RPE) cells from choroidal neovascularization (CNV) tissues used for patch-clamp analysis were immunostained against class III β-tubulin.
Confluent RPE cell cultures from CNV tissues were stained against glial acidic fibrillary protein (GFAP), endothelial factor 8, cytokeratin 18,
or vimentin.
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Figure 3. Effect of the dihydropyridine compound nifedipine on volt-
age-dependent Ba2+ currents of freshly isolated RPE cells.  A: Ba2+
currents induced by a 50 ms voltage-step from -70 mV to +10 mV in
a retinal pigment epithelium (RPE) cell freshly isolated from an eye
without choroidal neovascularization (CNV) under control condi-
tions and in the presence of nifedipine (10-5 M). B: Curves of volt-
age-dependent activation from six freshly isolated cells from eyes
without CNV: three cells under control conditions and three cells in
the presence of nifedipine. Currents were normalized to the maximal
current amplitude and fitted using the Boltzmann equation. C: Ba2+
currents induced by a 50 ms voltage-step from -70 mV to +10 mV in
an RPE cell freshly isolated from a CNV membrane under control
conditions and in the presence of nifedipine (10-5 M). D: Curves of
voltage-dependent activation from eight cells freshly isolated from
CNV membranes: six cells under control conditions and two cells in
the presence of nifedipine. Currents were normalized to the maximal
current amplitude and fitted using the Boltzmann equation. E: Com-
parison of the inhibitory effect of nifedipine in freshly isolated RPE
cells from eyes without CNV and from CNV tissues. Maximal cur-
rents at +10 mV under control conditions were set as 100%.
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Figure 4. Voltage-dependent Ba2+ currents in cultured cells.  A: Pattern of electrical stimulation to activate voltage-dependent Ba2+ currents. B:
Ba2+ inward currents in a cultured human retinal pigment epithelium (RPE) cell of an eye without choroidal neovascularization (CNV). C:
Current/voltage plot of currents from 10 cultured cells from eyes without CNV. D: Ba2+ inward currents in a cultured human RPE cell from
CNV tissue. E: Current/voltage plot from nine cultured cells from CNV membranes. F: Comparison of maximal Ba2+ densities at +10 mV in
cultured cells. G: Western blot of membrane proteins of cells from control eyes and CNV membranes. Left lane: staining for Cav1.2 (channel
α1C) subunits; right lane: staining for Cav1.3 (channel α1D) subunits.
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Figure 5. Effect of the dihydropyridine compound nifedipine on volt-
age-dependent Ba2+ currents of cultured retinal pigment epithelium
cells.  A: Ba2+ currents induced by a 50 ms voltage-step from -70 mV
to +10 mV (upper panel) in a cultured retinal pigment epithelium
(RPE) cell from an eye without choroidal neovascularization (CNV)
under control conditions and in the presence of nifedipine (10-5 M).
B: Curves of voltage-dependent activation from 14 cultured cells from
eyes without CNV: 10 cells under control conditions and four cells
in the presence of nifedipine. Currents were normalized to the maxi-
mal current amplitude and fitted using the Boltzmann equation. C:
Ba2+ currents induced by a 50 ms voltage-step from -70 mV to +10
mV in a cultured RPE cell from a CNV membrane under control
conditions and in the presence of nifedipine (10-5 M). D: Curves of
voltage-dependent activation from 13 cultured cells from CNV mem-
branes: nine cells under control conditions and four cells in the pres-
ence of nifedipine. Currents were normalized to the maximal current
amplitude and fitted using the Boltzmann equation. E: Comparison
of the inhibitory effect of nifedipine in cultured RPE cells from eyes
without CNV and from CNV tissues. Maximal currents at +10 mV
under control conditions were set as 100%.
450The (+) BayK8644 reduced the VEGF-A secretion rate in both
RPE cells from CNV membranes (Figure 6C) as well as in
cells from eyes without CNV (Figure 6B). To achieve a more
realistic stimulation of RPE cells, we used a test medium that
contained bFGF (10 ng/ml). In both, cells from CNV tissue
and cells from eyes without CNV, bFGF increased the VEGF
secretion rate. Further inhibition of voltage-dependent Ca2+
channels by nifedipine reduced the bFGF-induced increase in
the VEGF secretion rate (Figure 6D) to control values. In ad-
dition, bFGF increased L-type channel activity in RPE cells
from CNV membranes as well as in cells from eyes without
CNV (Figure 7D).
Regulation of voltage-dependent Ca2+ channels:  Since
the voltage-dependent Ca2+ channels mediate growth factor-
dependent secretion of VEGF, we studied the regulation of
these ion channels to find a possible link to how growth fac-
tors stimulate VEGF secretion by stimulation of Ca2+ chan-
nels. Intracellular application of the cytosolic subtype of ty-
rosine kinase pp60c-src (30 U/ml) during the whole-cell con-
figuration via the patch-pipette increased the maximal current
amplitude of L-type channels in RPE (n=4; Figure 7A). Ap-
plication of heat-inactivated pp60c-src did not change the L-
type channel activity (n=4). Furthermore, intracellular appli-
cation of pp60c-src accelerated time-dependent inactivation of
L-type channel currents (reduction of inactivation time con-
stant to 22±11% of control measured directly after breaking
into the whole-cell configuration; n=7; p=0.00036 paired test)
Thus, pp60c-src subtype of tyrosine kinase is an activator of L-
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Figure 6. Vascular endothelial growth factor secretion.  A: Increase of vascular endothelial growth factor (VEGF) concentration in the test
solution over time (each group: n=3 which represent 3 cultures from 3 different patients). B: Effect of L-type Ca2+ channel modulation
(inhibition: nifedipine, (+)BayK8644 enantiomer; activation: (-)BayK8644 enantiomer) on VEGF secretion by cells from eyes without CNV
(8 h values). C: Effect of L-type channel modulation (inhibition: nifedipine, 10-5 (+)BayK8644 enantiomer; activation: 10-5 (-)BayK 8644
enantiomer) on VEGF secretion rate in cells from choroidal neovascularization (CNV) membranes (8 h values). D: Effect of nifedipine on
basic fibroblast growth factor (bFGF) induced rise in the VEGF secretion rate by cells from eyes without CNV (left bars) and from CNV
membranes (right bars; 8 h values).
451type channel activity and modulator of L-type channel kinet-
ics in human RPE cells. Intracellular application of the active
pp60c-src to RPE cells from CNV membranes did not increase
the maximal current amplitude (n=3; Figure 7B) or change
the time-dependent inactivation (inactivation time constant
67±21% of control; n=4; not significant with paired test).
However, inhibition of pp60c-src by overnight incubation with
herbimycin A (10-5 M) or by 1 h incubation with SU6656 (10-
6 M, according to [36,37]) reduced the current density to the
same base level in both groups of cells. (Figure 7C). Thus, L-
type channels in cells from CNV membranes are activated by
src-subtype tyrosine kinase, but these channels cannot be fur-
ther stimulated by pp60c-src. However, as we demonstrated
bFGF can further stimulate L-type channel activity in cells
from CNV membranes (Figure 7D).
DISCUSSION
 The RPE is known to secrete a variety of growth factors [5-
7,38]. In this study, we provide insight into the mechanisms
that regulate their secretion rate. We found the rate of VEGF
secretion by human RPE cells is dependent on the activation
of L-type Ca2+ channels. Furthermore, RPE cells from CNV
tissue also maintained expression of voltage-dependent Ca2+
channels and secreted the angiogenic factor VEGF in response
to activation of these channels. Our observations might be of
importance to explore new strategies to prevent or reduce CNV.
Freshly isolated human RPE cells showed
dihydropyridine-sensitive voltage-dependent Ba2+ inward cur-
rents in response to depolarization to potentials more positive
than -30 mV from a holding potential of -70 mV. Thus, fresh
human RPE cells exhibited currents with properties of L-type
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Figure 7. Regulation of L-type channels.  A: Intracellular application of pp60c-src (30 U/ml) via the patch pipette in cultured cells from eyes
without choroidal neovascularization (CNV): change in maximal currents amplitudes by active pp60c-src versus heat-inactivated pp60c-src. B:
Intracellular application of pp60c-src via the patch pipette in cultured cells from CNV membranes: change in the maximal current amplitudes by
active pp60c-src versus heat-inactivated pp60c-src. C: Effect of the src-kinase inhibitors herbimycin A (10-5 M) and SU6656 (10-6 M) on current
density in cultured cells from eyes without CNV and from CNV membranes. D: Effect of basic fibroblast growth factor (bFGF) application
(10 ng/ml) on L-type currents in cultured cells from eye without CNV and from CNV membranes. Control represents current amplitude before
bFGF application, bFGF represents current amplitude after bFGF application.
452Ca2+ channels. We used a mixture of charge carrier ions of 1
mM Ca2+ and 10 mM Ba2+ to enhance seal formation and sta-
bility of the perforated-patch configuration. This would lead
to an anomalous mole fraction effect [39-41]. This effect arises
from the higher affinity of Ca2+ compared to Ba2+ at the selec-
tivity filter of the Ca2+ channel pore and leads to changes in
the current properties such as smaller amplitudes or even oc-
casional shifts in the voltage-dependence of the currents
[39,41]. However, the presence of L-type channels is in ac-
cordance with many studies using freshly isolated or cultured
RPE cells from various species [10-15,18,42,43]. The L-type
channel currents in freshly isolated human RPE cells exhib-
ited fast time-dependent activation, rather negative potential
of half-maximal activation, and were reduced to only 40% of
the control values in the presence of 10-5 M nifedipine, a rather
large concentration. With the low dihydropyridine sensitivity,
voltage-dependence, and kinetic behavior, the currents in
freshly isolated human RPE cells share characteristics with
currents exhibited by L-type Ca2+ channel α-subunit Cav1.3
investigated in a heterologous expression system [19-21]. The
dihydropyridine block was incomplete in which the currents
differ from those in heterologous expression system. How-
ever, characterization of Cav1.3 channels in native cells re-
vealed that these channels were also only incompletely blocked
by dihydropyridines at large concentrations [44]. Thus, the
currents in freshly isolated RPE cells from eyes without CNV
display characteristics of Cav1.3 channels by means of volt-
age-dependence, dihydropyridine sensitivity, and activation
kinetics. The application of nifedipine did not change the volt-
age-dependent activation of the channels. Thus, the L-type
channel blocker did not unmask another Ca2+ channel with a
different voltage-dependence contributing to the whole-cell
Ba2+ currents. The expression of the Cav1.3 subunit was con-
firmed by Western blot analysis of membrane proteins. The
predominant expression of Cav1.3 subunits in the RPE was
also described in rat and mouse cells [12,15,42,43]. However,
the L-type channel currents in human RPE cells showed a fast
inactivation with a time constant of 50 ms. Cav1.3 subunits in
a heterologous expression system showed almost no inactiva-
tion [19,20] except in one study [21]. The reason for this dif-
ference remains to be elucidated. It might be due to the ab-
sence of an anomalous mole fraction effect in other studies
that did not use extracellular solutions containing both Ba2+
and Ca2+, to different phosphorylation in native cells, or dif-
ferent composition of accessory subunits. Another possibility
might be the specific splice variant expressed in RPE cells
[42]. This splice variant has not been so far described to be
present in other tissues, and its characteristics are unknown.
The western blot analysis analysis also revealed a weak
expression of Cav1.2 (channel α1C) subunits. The time- and
voltage-dependent activation indicates that this subtype of L-
type channel might only weakly contribute to the whole-cell
Ba2+ currents in RPE cells, but it cannot be excluded.
The expression of Cav1.3 (or α1D subunits) known as
neuroendocrine L-type channels [16] in RPE cells implies a
role in the control of the secretory activity. Since expression
of L-type Ca2+ channels was maintained in cultured cells, we
analyzed effects of L-type channel modulation on VEGF se-
cretion by RPE cells in vitro. Direct modulation of L-type chan-
nels by application of the dihydropyridine compound
BayK8644 substantially changed the VEGF secretion rate.
Application of the Ca2+ channel activating enantiomer of
BayK8644 increased the VEGF secretion rate. The same was
observed by stimulation with low concentration of fetal calf
serum. Furthermore, application of bFGF stimulated both L-
type channel currents and VEGF secretion rate. The growth-
factor-stimulated increase in VEGF secretion was reduced by
L-type channel inhibition using nifedipine or the Ca2+ channel
blocking enantiomer of BayK8644. Thus, either direct or
growth-factor-dependent stimulation of L-type channels re-
sulted in an increase of the VEGF secretion rate. The underly-
ing growth-factor-dependent increase in L-type channel ac-
tivity might be achieved in two ways. First, the bFGF recep-
tor FGFR-2 can stimulate L-type channels by direct interac-
tion with the Cav1.3 subunit [15]. Second, the Cav1.3 subunit
in rat RPE was found to directly interact with the cytosolic
tyrosine kinase pp60c-src [12]. In human cells pp60c-src inhibi-
tion results in a decrease of L-type channel activity, whereas
intracellular application of pp60c-src leads to an increase of L-
type channel activity. Thus, pp60c-src constitutively maintains
a basic level of L-type channel activity, which can be further
increased. Since stimulation by several growth factors results
in an increase of pp60c-src activity, the growth-factor-depen-
dent stimulation of VEGF secretion might result from pp60c-
src-dependent activation of L-type channels.
Patch-clamp recordings with freshly isolated cells from
CNV revealed that RPE cells can maintain the expression of
voltage-dependent Ca2+ channels in disease. In a number of
investigated membranes, none of the RPE cells displayed any
voltage-dependent current. These cells showed a linear cur-
rent/voltage relationship with maximal current amplitudes in
the range of +/- 20 pA. This corresponds with observations in
histological investigations of CNV membranes. In these stud-
ies, RPE cells in CNV membranes appeared as atrophic cells,
a consequence of a disease that starts in the RPE [9]. How-
ever, we found that other CNV membranes contained RPE
cells appearing to be functional active cells. These cells ex-
pressed voltage-dependent Ca2+ channels. The currents acti-
vate at relatively positive potentials, showed fast activation
kinetics and were inhibited by the dihydropyridine nifedipine.
With these characteristics, the currents were comparable with
those in cells from eyes without CNV, mostly L-type channel
currents. However, currents in cells from CNV membranes
showed unusual fast inactivation kinetics, and the potential of
half-maximal activation was shifted to more negative poten-
tials. Thus, it could be that in these cells another voltage-de-
pendent Ca2+ channel contributes to the observed Ba2+ cur-
rents. Since application of nifedipine resulted in significant
current inhibition without shifts in the voltage-dependent ac-
tivation, the presence of nifedipine did not unmask the contri-
bution by another Ca2+ channel with different voltage-depen-
dence to the whole-cell currents. Furthermore, we could also
detect the presence of Cav1.3 subunits in RPE cells from CNV
tissues. Thus, it is likely that these L-type channels contrib-
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453ute, at least in part to the Ba2+ currents in these cells. In all
cells from CNV membranes, the voltage-dependent activa-
tion was shifted to more negative values, and the currents
reached their maximum more rapidly. Thus, in RPE cells from
CNV membranes, smaller depolarizing shifts in membrane
potential led to faster activation of L-type channels, which, in
turn, generated larger Ca2+ influxes into the cell. These differ-
ences could be again due to an anomalous mole fraction effect
on different Ca2+ channel subtypes [39,41]. Another reason
for this might be a higher pp60c-src-dependent stimulation of
L-type channels. CNV tissue represents a growth-factor-rich
environment [5,6,8,27,45] that should increase the pp60c-src
activity in general. Furthermore, intracellular application of
pp60c-src to RPE cells from control eyes resulted in faster inac-
tivation of L-type channel currents and has been found to shift
the potential of the half-maximal activation to more negative
values in rat RPE cells [12]. Since intracellular application of
pp60c-src did not further increase L-type channel activity in RPE
cells from CNV membranes, it appears that L-type channels
in these cells are maximally stimulated by this tyrosine ki-
nase. This is supported by the observation that inhibition of
pp60c-src in cells from CNV membranes reduced the L-type
channel activity to the same level as in cells from control eyes.
RPE cells from CNV membranes not only maintained the
expression of nifedipine-sensitive voltage-dependent Ca2+
channels, but the VEGF secretion rate is also dependent on
the activity of these channels. Application of nifedipine or the
Ca2+ channel inhibiting (+) enantiomer of BayK8644 signifi-
cantly reduced the VEGF-A secretion to the same level. The
Ca2+ channel activating (-) enantiomer of BaK8644 slightly,
but not significantly, increased VEGF-A secretion by RPE cells
from CNV membranes. This is not unlike experiments where
intracellular application of src-kinase was used to stimulate
Ca2+ channel activities in CNV RPE cells. Here, also, no fur-
ther stimulatory effect was observed. Several angiogenic and
growth factors are present in CNV membranes. Vitronectin
[46], a major component of drusen [47,48], VEGF [49] via
KDR/flk-1 receptor expressed by RPE cells [50,51], or IGF-1
[25-27,52,53] act via activation of the src-subtype tyrosine
kinase, and many are produced by the RPE [5-7,22-27] and
bFGF [54]. We propose that the secretion of these factors is
regulated by L-type channels at the beginning of the disease.
In the progression of the disease growth of CNV tissue is pro-
moted by VEGF-A secretion under control of nifedipine-sen-
sitive voltage-dependent Ca2+ channels. The CNV membranes,
which were found to contain RPE cells with active Ca2+ chan-
nels, might reflect a state of active CNV development. Ca2+
channel activity and VEGF secretion rate appears to be higher
in cells from CNV tissues compared to cells from eyes with-
out CNV. Immunohistological analysis of RPE cell cultures
from CNV tissues revealed that these cultures contained ho-
mogeneous RPE cells. RT-PCR analysis revealed the expres-
sion of the RPE marker RPE65 in these cultures [31]. The
presence of endothelial cells could be excluded by absence of
endothelial factor 8 staining, and the presence of glia cells
could by excluded by absence of GFAP staining. It is unlikely
that cultured photoreceptors or neurons were present.
It is intriguing to argue that this might be a pathophysi-
ological effect. However, this could also be an effect resulting
from a different reaction to the experimental procedures. In
contrast, taking the different Ca2+ channel properties into ac-
count it might be that RPE cells in the proliferating CNV tis-
sue underwent a transdifferentiation into a different pheno-
type, which is characterized by predominant growth factor
secretion. This phenotype is maintained in culture as can be
seen by the conserved Ca2+ channel characteristics. As already
stated, these characteristics could be due to the expression of
additional Ca2+ channel subtypes.
In summary, we showed for the first time that regulation
of the angiogenic factor secretion rate by human RPE cells
involves the activation of voltage-dependent L-type Ca2+ chan-
nels. Since a changed growth factor secretion by the RPE is
thought to play a role in the induction of various eye diseases
involving cell proliferation, voltage-dependent Ca2+ channels
or their regulatory proteins could be included as targets in thera-
peutic strategies acting directly at the secretion site of angio-
genic factors.
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